CEO SUMMARY: CMS wanted more power to cut the prices it pays for clinical lab testing. A significant part of the lab industry wanted more transparency and consistency in how CMS established coverage guidelines and prices for new lab tests. Congress appears to have attempted to craft a law intended to support both objectives. Now, …
New Federal Law Changes How CMS Sets Lab Prices Read More »
To access this post, you must purchase The Dark Report.